| [1] |
Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
| [2] |
Gu Anqin, Long Jinhua, Jin Feng.Clinical research progress of immunotherapy for nasopharyngeal carcinoma[J]. Journal of International Oncology, 2023, 50(5): 299-303. |
| [3] |
Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen.Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system[J]. Journal of International Oncology, 2021, 48(9): 515-522. |
| [4] |
Peng Ya, Liu An, Liu Huowang.Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice[J]. Journal of International Oncology, 2021, 48(3): 136-142. |
| [5] |
Zhu Lei, Huang Jianbo.Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(2): 74-79. |
| [6] |
Luo Wenxiao, Wu Dehua, Cai Longmei.Prognostic values of immune efficacy biomarkers in the treatment of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(12): 743-746. |
| [7] |
Yang Minghui, Jin Feng.Value of 3D-ASL, MRS and DTI in the diagnosis and treatment of radiation-induced temporal lobe injury of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2020, 47(9): 550-554. |
| [8] |
Yang Chao, Wang Jianbo, Zhang Juhong, Wang Jialong.Overexpression of miR-125 inhibits proliferation and invasion of nasopharyngeal carcinoma cells by down-regulating FGF-2[J]. Journal of International Oncology, 2020, 47(5): 257-263. |
| [9] |
Shen Jianjun.Treatment of local recurrenct nasopharyngeal carcinoma after radiotherapy[J]. Journal of International Oncology, 2020, 47(4): 227-230. |
| [10] |
Zhou Yuanyuan, Li Jing.Clinical practice value of hematological inflammation biomarkers in nasopharyngeal carcinoma[J]. Journal of International Oncology, 2019, 46(8): 492-495. |
| [11] |
Zhou Ping, Chen Weisi, Zhang Shuang, Lin Bing, Pan Tao, Liu Sha.Observation of efficacy of paclitaxel with concurrent radiotherapy in the treatment for nasopharyngeal carcinoma patients with liver metastasis[J]. Journal of International Oncology, 2019, 46(6): 327-330. |
| [12] |
CHEN Jiong-Yu, ZHUANG Yi-Xuan, ZHUANG Shan-Shan, PENG Lin.Effects of osthole on the proliferation, invasion and migration of nasopharyngeal carcinoma cells CNE2[J]. Journal of International Oncology, 2018, 45(8): 453-459. |
| [13] |
LAI Shi-Jia, ZHAO De-An, SUN Yong-Ming.Expression and clinical significance of serum microRNA663 in nasopharyngeal carcinoma patients[J]. Journal of International Oncology, 2018, 45(8): 460-464. |
| [14] |
Qiao Yunfeng, Li Ping, Fu Zhenming.Clinical application of cisplatin and nedaplatin[J]. Journal of International Oncology, 2018, 45(8): 561-565. |
| [15] |
Huang Ting, Song Xuewei, An Shufen, Wang Zhibin, Liao Hehe.Expressions of MDR-1 and P-gp in human nasopharyngeal squamous cell carcinoma CNE1 cell line after X-ray exposure[J]. Journal of International Oncology, 2018, 45(6): 321-324. |
